Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Han, Sang-oh, Ronzitti, Giuseppe, Arnson, Benjamin, Leborgne, Christian, Li, Songtao, Mingozzi, Federico, Koeberl, Dwight
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500922/
https://www.ncbi.nlm.nih.gov/pubmed/31073535
http://dx.doi.org/10.1016/j.omtm.2019.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500922/
https://www.ncbi.nlm.nih.gov/pubmed/31073535
http://dx.doi.org/10.1016/j.omtm.2019.04.005

Ejemplares similares